BioBoss

28 Feb 2026 05:00

David Southwell: CEO of Volastra Therapeutics

David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.

Отзывы

Podcastly – the best platform for podcasters and podcast lovers. More than 10 millions of audio content that available on Android/iOS/Web/Desktop and Telegram.

Social networks

Select language

🇺🇸